Financhill
Back

Denali Therapeutics Quote, Financials, Valuation and Earnings

Denali Therapeutics Price Quote

$27.01
-0.04 (4.04%)
(Updated: November 2, 2024 at 4:07 AM ET)

Denali Therapeutics Key Stats

Sell
50
Denali Therapeutics (DNLI) is a Sell

Day range:
$26.27 - $27.49
52-week range:
$14.56 - $32.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.79
P/B ratio:
2.79%

Volume:
837.2K
Avg. volume:
701K
1-year change:
42.14%
Market cap:
$3.9B
Revenue:
$330.5M
EPS:
$-2.85

How Much Does Denali Therapeutics Make?

Data Unavailable

Is Denali Therapeutics Growing As A Company?

Data Unavailable

Denali Therapeutics Stock Price Performance

What Is Denali Therapeutics 52-Week High & Low?

Denali Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Denali Therapeutics?

Is Denali Therapeutics Cash Flow Positive?

  • What Is DNLI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$390.9M
  • What Is Denali Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $514.2M
  • What Is Denali Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$180.7M

Denali Therapeutics Return On Invested Capital

Data Unavailable

Denali Therapeutics Earnings Date & Stock Price

Denali Therapeutics Competitors

  • Who Are Denali Therapeutics's Competitors?
    Below is a list of companies who compete with Denali Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Protalix BioTherapeutics Inc (PLX)

Denali Therapeutics Dividend Yield

Denali Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.95%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 41.15
Upside from Last Price: 52.14%

Major Shareholders

  • How many DNLI shares are owned by institutional investors?
    240.7M DNLI shares are owned by institutional investors
  • How many DNLI shares are owned by insiders?
    2.7M DNLI shares are owned by insiders